Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

38 Press Releases
DateTitleCompany
18 Dec 12 Positive response from European regulatory procedure supports approval of Elvanse® (lisdexamfetamine dimesylate) for ADHD Shire plc
06 Sep 12 Shire Settles All Pending Litigation With Anchen and TWi Concerning INTUNIV® Shire plc,
Published by
PR Newswire
13 Apr 12 Shire adds new technology platform and phase 2 product candidate to its Regenerative Medicine business Shire plc
12 Apr 12 Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012 Shire plc,
Published by
PR Newswire
01 Mar 12 Shire Receives Prestigious EURORDIS Company Award for Exemplary Work in Rare Diseases SHIRE PLC
24 Jun 11 European Authorities Approve New Manufacturing Facility for Shire's REPLAGAL® (agalsidase alfa) Shire plc,
Published by
PR Newswire
18 Mar 11 European Commission Approves Self-Administration Label for FIRAZYR® (icatibant) for the Symptomatic Treatment of Acute Hereditary Angioedema Attacks Shire plc,
Published by
PharmiWeb.com
03 Mar 11 European Commission Approves Self-Administration Label for FIRAZYR(R) (icatibant) for the Symptomatic Treatment of Acute Hereditary Angioedema Attack Shire plc,
Published by
PharmiWeb.com
01 Dec 10 Shire Reports Positive Efficacy and Safety Results From FAST-3 Study of FIRAZYR® (icatibant) for Acute Attacks of Hereditary Angioedema Shire plc,
Published by
PharmiWeb.com
18 Oct 10 Third Quarter 2010 Results Date Notification - October 29, 2010 Shire plc,
Published by
PR Newswire
14 Sep 10 Shire Update on ProAmatine® (midodrine HCl) Shire plc,
Published by
PharmiWeb.com
26 Aug 10 Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease Shire plc,
Published by
PR Newswire
17 Aug 10 Shire plc - Statement re ProAmatine Shire plc,
Published by
PR Newswire
03 Jun 10 INTUNIV(TM) - Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc. Shire plc,
Published by
PR Newswire
29 May 10 Shire Receives LIALDA(R) Paragraph IV Notice Letter From Zydus Pharmaceuticals Shire plc,
Published by
PR Newswire
19 May 10 Shire Receives 2010 Corporate Award From the National Organization for Rare Disorders (NORD) for the Development of VPRIV (velaglucerase alfa for Injection) Shire plc,
Published by
PR Newswire
13 May 10 INTUNIV(TM) - Shire Files Suit Against Actavis Elizabeth LLC and Actavis Inc. Shire plc,
Published by
PR Newswire
29 Apr 10 Shire's Replenished Portfolio Drives Excellent Quarterly Performance Shire plc,
Published by
PR Newswire
27 Apr 10 Shire Receives INTUNIV(TM) Paragraph IV Notice Letter From Anchen Shire plc,
Published by
PR Newswire
23 Apr 10 INTUNIV(TM) - Shire Files Suit Against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. Shire plc,
Published by
PR Newswire
16 Mar 10 Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals Shire plc,
Published by
PR Newswire
15 Mar 10 New Board Director Appointed Shire plc,
Published by
PR Newswire
04 Mar 10 District Court Upholds FDA's Grant of 5-Year Market Exclusivity to VYVANSE(R) Shire plc,
Published by
PR Newswire
11 Feb 10 Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease Shire plc,
Published by
PR Newswire
04 Feb 10 Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA) Shire Plc,
Published by
PR Newswire
03 Feb 10 Shire to Present Important Study Findings for Gaucher Disease Treatment and GLD Development Program at the Lysosomal Disease Network (LDN) World Symposium Shire plc,
Published by
PR Newswire
02 Dec 09 Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic Shire Plc,
Published by
PR Newswire
24 Nov 09 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease Shire Plc,
Published by
PR Newswire
06 Nov 09 New Shire Board Member Shire Plc,
Published by
PR Newswire
04 Nov 09 FDA Grants Priority Review for Shire's velaglucerase alfa for Type 1 Gaucher Disease Shire Plc,
Published by
PR Newswire
Advertising